[1] 孙田.白芍总苷联合复方氟米松软膏治疗寻常性银屑病的临床疗效及不良反应[J].中国医学科学,2015,5(4):13-16.
[2] 何春峰,吴爱萍,张丽,等.白芍总苷联合窄谱中波紫外线及卡泊三醇治疗中度寻常性银屑病78例疗效分析[J].中国皮肤性病学杂志,2014,28(8):873-875.
[3] DAS D,AKHTAR S,KURRA S,et al.Emerging role of immune cell network in autoimmune skin disorders:An update on pemphigus,vitiligo and psoriasis[J].Cytokine Growth Factor Rev,2019,45:35-44.
[4] 黄英梅,毕健平,张洪英,等.窄谱中波紫外线对寻常性银屑病患者外周血纤溶酶及CC趋化因子配体20水平的影响[J].中华皮肤科杂志,2017,50(3):591-594.
[5] ZHENG Q,SUN X Y,MIAO X,et al.Association between physical activity and risk of prevalent psoriasis:A MOOSE-compliant meta-analysis [J].Medicine,2018,97(27):11394.
[6] MROWIETZ U,REICH K.Psoriasis--new insights into pathogenesis and treatment [J].Dtsch Arztebl Int,2009,106(1-2):11-19.
[7] 李加文,李东升,刘厚军,等.寻常性银屑病患者皮损白介素17、干扰素γ及巨噬细胞炎性蛋白-3αmRNA的表达[J].中华皮肤科杂志,2004,37(3):150-152.
[8] 王晓琴,慕珍珍,韩秀萍,等.CCL20、CCR6及IL-17A在寻常型银屑病患者血清中的表达及意义[J].中国中西医结合皮肤性病学杂志,2017,16(2):122-124.
[9] 谢湘江,王颖,陈维文,等.趋化因子CCL20在银屑病皮损中的表达及作用[J].免疫学杂志,2017,33(6):505-511.
[10] 张育贵,张淑娟,边甜甜,等.芍药苷药理作用研究新进展[J].中草药,2019,50(15):3735-3739.
[11] 张建军,黄银峰,王丽丽,等.白芍、赤芍及芍药苷、芍药内酯苷对综合放血法致血虚小鼠补血作用的比较研究[J].中国中药杂志,2013,38(19):3358-3362.
[12] LI B,HE S,LIU R,et al.Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation[J].J Ethnopharmacol,2019,243:112121.
[13] 周骢骢,陈宏,苏彤,等.白芍总苷联合丁酸氢化可的松乳膏治疗前后寻常性银屑病患者外周血白介素25和胸腺基质淋巴细胞生成素mRNA表达变化[J].临床皮肤科杂志,2016,45(6):250-253.
[14] 郭洪飞,徐学娟.白芍总苷胶囊辅助治疗银屑病的效果及对病人血清中IL-17、IL-18、INF-γ水平的影响 [J].中国校医,2019,33(9):663-691.
[15] 张宇虹,郭在培,焦晓燕,等.白芍总苷对寻常型银屑病患者血清白介素-22的影响[J].华西医学,2012,27(4):542-544.
[16] PANG W,QI X,CAO C,et al.Inhibitory effects of TGP on KGF induced hyper- proliferation of HaCaT cells via suppression of the p38 MAPK/NF-κB p65 pathway [J].Mol Med Rep,2018,22(10):1337-1339. |
